Serum levels of soluble interleukin-2 receptors and their relation to lymphocyte subpopulations in patients with metastatic solid tumours.

Ítems similars

• Serum interleukin-2 levels in relation to the neuroendocrine status in cancer patients.
  per: Lissoni, P., et al.
  Publicat: (1990)
• A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma.
  per: Lissoni, P., et al.
  Publicat: (1994)
• A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients.
  per: Lissoni, P., et al.
  Publicat: (1996)
• Pretreatment serum markers and lymphocyte response to interleukin-2 therapy
  per: Fumagalli, L, et al.
  Publicat: (1999)
• Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer.
  per: Lissoni, P., et al.
  Publicat: (1992)